Adagrasib and Pasireotide: Interaction Details

Brand names
Adagrasib
Krazati
Pasireotide
Signifor
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Pasireotide

Brand name
  • Signifor

We don't have a drug information page for Pasireotide yet. Have a question about Pasireotide? Ask a pharmacist, free →

What Happens When You Take Adagrasib With Pasireotide

What can happen when they are taken together (rated Major)

An increased risk of , , polymorphic ventricular , other serious

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Adagrasib should not be combined with other products known to have the potential to prolong the . Because adagrasib itself prolongs the QTc interval, taking it together with other QTc-prolonging products can produce a larger increase in the QTc interval, along with adverse reactions linked to that prolongation, such as torsade de pointes, other serious arrhythmias, and sudden death.

An and electrolytes should be checked before adagrasib is started and during , and again as clinically indicated, in patients with congestive heart failure, bradyarrhythmias, or electrolyte abnormalities, and in those who cannot avoid medications known to prolong the . Adagrasib should be withheld if the QTc interval exceeds 500 msec or if the change from baseline exceeds 60 msec, until the QTc interval falls below 481 msec or returns to baseline.

Treatment is then resumed at the next lower dose level. Adagrasib should be permanently discontinued if torsade de pointes, polymorphic ventricular tachycardia, or signs or symptoms of a serious or life-threatening arrhythmia occur.1

The Adagrasib and Pasireotide Interaction, Explained

Adagrasib (Krazati) is a cancer medicine that can slightly lengthen the time your heart takes to recharge between beats. This is called . Pasireotide (Signifor), used for Cushing's disease or acromegaly, can do the same thing. Taking both could add up and, in rare cases, trigger a dangerous heart rhythm problem.

This risk is based on how the drugs work rather than on studies of the two together. Still, it is taken seriously. Please don't stop or change either medicine on your own. Your care team may check your heart tracing () and your potassium and magnesium levels, and can adjust your treatment if needed. Tell them right away if you feel fainting, a racing or pounding heartbeat, or severe dizziness.

Mechanism: (). Adagrasib prolongs , and pasireotide is also associated with QT prolongation. Neither drug's effect depends on activation. Risk includes , polymorphic VT, and sudden death.

Evidence: theoretical, with no direct combination data. Severity is rated major. Onset is unspecified.

  • Avoid the combination if possible.
  • If unavoidable, obtain and electrolytes (especially K and Mg) at baseline, during use, and as clinically indicated (CHF, bradyarrhythmias, electrolyte abnormalities).
  • Withhold adagrasib if QTc is above 500 msec or the change from baseline is above 60 msec, until QTc is below 481 msec or at baseline. Resume at the next lower dose level.
  • Permanently discontinue adagrasib for torsade, polymorphic VT, or signs of serious .

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Adagrasib and Pasireotide Interact

The likely mechanism


In short: Adagrasib and pasireotide both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Adagrasib and Pasireotide Interaction

The safest approach is usually to avoid combining these medicines. If your team decides you need both, they can manage the risk with careful monitoring.

  • Keep taking both as prescribed unless your prescriber tells you otherwise.
  • Expect an and blood tests for electrolytes (such as potassium and magnesium) before starting and during treatment, and as needed afterward.
  • If your heart tracing changes too much, your doctor may pause adagrasib and restart it at a lower dose, or stop it if a serious rhythm problem occurs.
  • Tell your pharmacist or prescriber about heart failure, a slow heartbeat, or electrolyte problems, and about any other medicines you take.
  • Seek urgent care for fainting, a racing or irregular heartbeat, or seizure-like episodes.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Adagrasib or Pasireotide need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Adagrasib and Pasireotide: Common Questions

How serious is the Adagrasib and Pasireotide interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Adagrasib and Pasireotide interaction managed?

The safest approach is usually to avoid combining these medicines. If your team decides you need both, they can manage the risk with careful monitoring. Keep taking both as prescribed unless your prescriber tells you otherwise. Expect an and blood tests for electrolytes (such as potassium and magnesium) before starting and during treatment, and as needed afterward. If your heart tracing change… Management is individual — always follow your own care team's guidance.

Who is at higher risk from the Adagrasib and Pasireotide interaction?

The interaction record names these groups as more likely to be affected:

  • People with low potassium or magnesium
  • People with heart disease or heart failure

If this describes you, tell your pharmacist or prescriber.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Adagrasib and Pasireotide Interaction

Ask in your own words about taking Adagrasib and Pasireotide together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: KRAZATI(TM) oral tablets, adagrasib oral tablets. Mirati Therapeutics Inc (per FDA), San Diego, CA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Adagrasib and Pasireotide

Also serious with Adagrasib

Also serious with Pasireotide

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Adagrasib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.